Table I.
Summary of laboratory findings and common ocular findings in El Bagre-endemic pemphigus foliaceus
| Sex | DX | DIF IgG1 |
DIF IgG total |
IIF IgG4 |
IB-160 | IP 45, 200, 117, 89, 34 |
Red eye | Clinical entropion and/or ectropion, trichiasis, blepharophimosis, thinned eyebrows |
|---|---|---|---|---|---|---|---|---|
| F | El Bagre-EPF 1 | (−) | (+++) | (++) | (++) | (+++) | (+++) | (+++) |
| M | El Bagre-EPF 2 | (−) | (++) | (++) | (1/2 +) | (++) | (++) | (++) |
| F | El Bagre-EPF 3 | (−) | (+++) | (+++) | (++) | (+++) | (++) | (++) |
| M | El Bagre-EPF 4 | (−) | (−) | (+) | (−) | (1/2 +) | (+++) | (+++) |
| M | El Bagre-EPF 5 | (−) | (+) | (++) | (1/2 +) | (+) | (+) | (+) |
| M | El Bagre-EPF 6 | (−) | (++) | (+++) | (−) | (++) | (++) | (++) |
| M | El Bagre-EPF 7 | (−) | (++) | (++) | (+++) | (+++) | (+++) | (+++) |
| M | El Bagre-EPF 8 | (−) | (++) | (+++) | (++) | (++++) | (−) | (−) |
| M | El Bagre-EPF 9 | (−) | (++) | (+++) | (++) | (++++) | (++++) | (++++) |
| M | El Bagre-EPF 10 | (−) | (++) | (++) | (−) | (++) | (++) | (++) |
| M | El Bagre-EPF 11 | (−) | (++) | (++) | (+++) | (+++) | (+++) | (+++) |
| M | El Bagre-EPF 12 | (−) | (++) | (+++) | (−) | (++) | (+++) | (+++) |
| M | PE | (−) | (++) | (+++) | (−) | (++) | (++) | (++) |
| M | PF 1 | (−) | (−) | (+++) | (++) | (45 Only) | (+) | (+) |
| M | PF 2 | (−) | (−) | (+++) | (++) | (200, 45, 34) | (++) | (++) |
| M | NHS 1 | (−) | (−) | (−) | (−) | (−) | (−) | (−) |
| M | NHS 2 | (−) | (−) | (−) | (−) | (−) | (−) | (−) |
DIF, Direct immunofluorescence; DX, diagnosis; EPF, endemic pemphigus foliaceus; F, female; IB, immunoblotting; IIF, indirect immunofluorescence; IP, immunoprecipitation; M, male; NHS, normal human serum; PE, pemphigus erythematosus; PF, pemphigus foliaceus.